Intravenous ketamine delivered during surgical anesthesia has no greater effect than placebo in reducing severity of depression.
FDA allows Florida to import cheaper drugs from Canada
Jan 05, 2024
The plan would let Florida buy selected drugs in bulk from Canada, following FDA review.
Risk profile IDs COVID-19 patients who will benefit from baricitinib
Feb 26, 2024
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
CVD mortality similar with diuretic, ACE inhibitor, or calcium channel blocker
Dec 04, 2023
Those randomly assigned to receive ACE inhibitor had an increased risks for stroke mortality and fatal and nonfatal hospitalized stroke versus the diuretic group.
Congress, CMS clash over AI role in Medicare claims denials
By
Aaron Dorman
Nov 07, 2023
Thirty House Democrats released a letter Friday urging CMS to take several steps to make sure AI is not unfairly denying coverage.
Virtual community of long-term care and other providers commits to ‘age-friendly’ care guidelines
By
Aaron Dorman
Nov 03, 2023
Recruiting has begun for providers for the fifth iteration of an ‘age friendly’ network who will have access to webinars, coaching and more.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Fatal drug overdoses quadrupled from 1999 to 2020
Sep 19, 2023
The highest rate increases were seen in white and Native American or Alaskan Native individuals and in the Midwest and nonmetro areas.
Med-management software company releases new tool for nursing facilities to meet new need for CMS compliance
By
Aaron Dorman
Sep 20, 2023
To meet new CMS rules for nursing homes, one company is releasing a new service that focuses on ensuring a patient’s medication listings are up-to-date.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.